Inventor
NEWMAN ROLAND A
US18 patents
⚠️ This page may combine multiple inventors who share the name “NEWMAN ROLAND A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDEC PHARMA CORP
12 patentsUS6682734B1Jan 27, 2004
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IDEC PHARMA CORP176 citations99
US6399061B1Jun 4, 2002
Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma
IDEC PHARMA CORP254 citations99
US6001358ADec 14, 1999
Humanized antibodies to human gp39, compositions containing thereof
IDEC PHARMA CORP125 citations99
US5776456AJul 7, 1998
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IDEC PHARMA CORP527 citations99
US5736137AApr 7, 1998
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IDEC PHARMA CORP1,577 citations99
US5756096AMay 26, 1998
Recombinant antibodies for human therapy
IDEC PHARMA CORP175 citations98
US5750105AMay 12, 1998
Recombinant antibodies for human therapy
IDEC PHARMA CORP318 citations98
US5693780ADec 2, 1997
Recombinant antibodies for human therapy
IDEC PHARMA CORP485 citations98
US5681722AOct 28, 1997
Recombinant antibodies for human therapy
IDEC PHARMA CORP158 citations98
US5658570AAug 19, 1997
Recombinant antibodies for human therapy
IDEC PHARMA CORP695 citations98
US6440418B1Aug 27, 2002
Methods of treating autoimmune diseases with gp39-specific antibodies
IDEC PHARMA CORP36 citations92
US6506383B1Jan 14, 2003
Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies
IDEC PHARMA CORP9 citations74
BIOGEN IDEC INC
5 patentsUS7422739B2Sep 9, 2008
Anti-CD20 antibodies
BIOGEN IDEC INC166 citations99
US7381560B2Jun 3, 2008
Expression and use of anti-CD20 antibodies
BIOGEN IDEC INC45 citations96
US7744877B2Jun 29, 2010
Expression and use of anti-CD20 Antibodies
BIOGEN IDEC INC38 citations92
US7074406B2Jul 11, 2006
Treating allergic diseases with humanized anti-CD40L antibody
BIOGEN IDEC INC14 citations92
US7122187B2Oct 17, 2006
Treating autoimmune diseases with humanized anti-CD40L antibody
BIOGEN IDEC INC23 citations89